DigestZen

by doTERRA · liquid · 5 mL

  • On the market (NIH)
  • DSLD label 267289
  • Serving 1 drop (60 mg)
  • 85 servings

DigestZen by doTERRA lists 7 ingredients; 7 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on August 23, 2022.

What is in DigestZen?

Each row as the label prints it, per serving of 1 drop. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

DigestZen: Supplement Facts rows against the market (DSLD label 267289, January 2026 release)
IngredientAmount% DVAmong products listing it
DigestZen Digestive Blend60 mg
Peppermintas Peppermint, Peppermintin the blend, no amount given
Corianderin the blend, no amount given
Gingeras Ginger, Gingerin the blend, no amount given
Carawayin the blend, no amount given
Cardamomin the blend, no amount given
Fennelin the blend, no amount given
Star Aniseas Star Anise, Star Anisein the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 267289 (entered August 23, 2022), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 7 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with DigestZen's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
For aromatic or topical use. Diffuse aromatically or, to apply topically, dilute with a carrier oil to minimize skin sensitivity.
For internal use dilute one drop in 4 fl. oz. of liquid.
Warnings
Caution: Possible skin sensitivity.
Keep away from children.
Consult your doctor if pregnant or in treatment.
Avoid eyes, inner ears, and sensitive areas.

Source: label statements in DSLD label 267289.

What else is on the label?

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): CPTG Certified Pure Tested Grade.

How many labels does DigestZen have?

4 labels are on file under this name since May 28, 2019: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 267289 (current) Entered August 23, 2022 · on the market · 5 mL
  2. Label 267290 Entered June 16, 2022 · on the market · 15 mL
  3. Label 202774 Entered July 24, 2019 · on the market · 5 mL
  4. Label 202920 Entered May 28, 2019 · on the market · 15 mL

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names doTERRA Intl, LLC (manufacturer), Pleasant Grove, UT. All doTERRA products.

Where next?